peptide drugs

PeptiDream and France-Based Ipsen Have Expanded Their Research Collaboration
Oct 9, 2013
Japanese pharmaceutical firm PeptiDream and France-based Ipsen have expanded their research collaboration and license option agreement signed in April 2013 to develop peptide drugs to treat serious endocrinologic disease. The deal has now ...

Tags: PeptiDream, Ipsen, peptide drugs
ScinoPharm and Foresee Pharmaceuticals Have Signed an Agreement
Feb 1, 2013
ScinoPharm and Foresee Pharmaceuticals have signed an agreement to form a joint venture for developing a series of peptide injectable drugs with the first being a new oncological Leuprolide injectable drug used for treating prostate cancer. ...

Tags: ScinoPharm, Foresee Pharmaceuticals, joint venture
Aileron Therapeutics Has Secured The Second Tranche in Its Series D Financing
Jan 17, 2013
Aileron Therapeutics has secured the second tranche in its series D financing, meaning the overall total has now reached $42 million (pound 26 million). This payment followed the successful progression of the company's ALRN-5281 lead ...

Tags: Aileron Therapeutics, tranche, clinical development